Asmanex Twisthaler Side Effects
Generic name: mometasone
Medically reviewed by Drugs.com. Last updated on Aug 3, 2024.
Note: This document contains side effect information about mometasone. Some dosage forms listed on this page may not apply to the brand name Asmanex Twisthaler.
Applies to mometasone: implantation implant. Other dosage forms:
Serious side effects of Asmanex Twisthaler
Along with its needed effects, mometasone (the active ingredient contained in Asmanex Twisthaler) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking mometasone:
More common
- Chest tightness
- chills
- cough producing mucus
- earache
- ear congestion
- feeling faint
- fever
- headache
- lightheadedness
- loss of voice
- noisy breathing
- nosebleeds
- pain or tenderness around the eyes and cheekbones
- redness or swelling in the ear
- sneezing
- sore throat
- stuffy or runny nose
- trouble breathing
Less common
- Blurred vision
- body aches or pain
- fast heartbeat
- hives, itching, skin rash
- hoarseness
- irritation
- joint pain, stiffness, or swelling
- muscle weakness
- redness of the skin
- swelling of the eyelids, face, lips, hands, or feet
- trouble swallowing
- unusual tiredness or weakness
Incidence not known
- Burning, redness, swelling, or irritation around or inside your nose
- darkening of the skin
- diarrhea
- dizziness
- eye pain
- loss of appetite
- mental depression
- nausea or vomiting
- sores or white patches inside the nose or mouth
For Healthcare Professionals
Applies to mometasone: inhalation aerosol, inhalation aerosol powder.
Gastrointestinal
Very common (10% or more): Oral candidiasis
Uncommon (0.1% to 1%): Dry mouth and throat, dyspepsia[Ref]
In clinical trials, gastroenteritis and vomiting occurred with an incidence of at least 1% but less than 3%.[Ref]
Nervous system
Very common (10% or more): Headache[Ref]
Respiratory
Very common (10% or more): Nasopharyngitis, allergic rhinitis, upper respiratory infection
Common (1% to 10%): Sinusitis, bronchitis, pharyngitis, dysphonia, epistaxis, nasal irritation, respiratory disorder
Postmarketing reports: Asthma aggravation, which may include cough, dyspnea, wheezing and bronchospasm[Ref]
Genitourinary
Common (1% to 10%): Dysmenorrhea, urinary tract infection (in pediatrics)[Ref]
Musculoskeletal
Common (1% to 10%): Musculoskeletal pain, back pain, myalgia[Ref]
Other
Common (1% to 10%): Fatigue, flu-like symptoms, pain, earache, infection, fever and bruise (in pediatrics)[Ref]
In clinical trials, fatigue, flu-like symptoms, pain, earache, and infection occurred with an incidence of at least 1% but less than 3%.[Ref]
Cardiovascular
Uncommon (0.1% to 1%): Palpitations[Ref]
Metabolic
Uncommon (0.1% to 1%): Weight increase[Ref]
Ocular
Rare (less than 0.1%): Glaucoma, cataracts
Postmarketing reports: Vision blurred[Ref]
Psychiatric
Frequency not reported: Psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression[Ref]
Hypersensitivity
Postmarketing reports: Immediate and delayed hypersensitivity reactions including rash, pruritus, angioedema and anaphylactic reaction[Ref]
Frequently asked questions
More about Asmanex Twisthaler (mometasone)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (23)
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: inhaled corticosteroids
Patient resources
- Asmanex drug information
- Asmanex Twisthaler 120 Dose
- Asmanex Twisthaler 60 Dose
- Asmanex Twist (Advanced Reading)
- Asmanex 120 Metered Doses
Other brands
Professional resources
Other brands
Related treatment guides
References
1. (2005) "Product Information. Asmanex Twisthaler (mometasone)." Schering-Plough Corporation
2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
3. (2014) "Product Information. Asmanex HFA (mometasone)." Merck & Co., Inc
4. US Food and Drug Administration (2018) Drug Safety Label Changes (SLC): Asmanex HFA. https://www.accessdata.fda.gov/scripts/cder/safetylabelingchanges/index.cfm?utm_campaign=SLC%203%2F30&utm_medium=email&utm_source=Eloqua&event=searchdetail.page&DrugNameID=329&elq
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.